Vortioxetine Hydrobromide

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

45 API Suppliers, 24 USDMF, 3 JDMF, 5 EU WC, 9 KDMF, 8 NDC API, 30 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

5 Drugs in Development

5 Drugs in Development

INTERMEDIATES

9 Intermediates Suppliers

9 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

79 FDF Dossiers, 18 FDA Orange Book, 30 Europe, 3 Canada, 15 South Africa, 13 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE, TABLET;ORAL - EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 20MG BASE, TABLET;ORAL - EQ 5MG BASE

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 13 SPI Pharma, 2 DKSH, 2 Faran Shimi Pharmaceutical, 7 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 BASF, 1 Clariant, 3 DFE Pharma, 4 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 5 Kerry, 9 Microlex e.U, 2 Pharmatrans-Sanaq, 2 Pluviaendo, 3 Prachin Chemical, 14 Roquette, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

37 Fillers, Diluents & Binders, 22 Direct Compression, 14 Disintegrants & Superdisintegrants, 13 Thickeners and Stabilizers, 12 Co-Processed Excipients, 11 Lubricants & Glidants, 11 Chewable & Orodispersible Aids, 11 Taste Masking, 9 Granulation, 8 Coating Systems & Additives, 5 Parenteral, 4 Controlled & Modified Release, 4 Film Formers & Plasticizers, 2 Rheology Modifiers, 2 Topical, 2 Coloring Agents, 1 Emulsifying Agents, 1 API Stability Enhancers, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

5 DATA COMPILATION #PharmaFlow, 44 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 25 Finished Drug Prices, 17 Annual Reports

MARKET PLACE

8 APIs, 4 FDF Dossiers, 1 Intermediates

PATENTS & EXCLUSIVITIES

80 US Patents, 12 US Exclusivities, 12 Health Canada Patents

REF. STANDARDS & IMPURITIES

8 Others

8 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 204447 / DOSAGE - TABLET;ORAL - EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
VORTIOXETINE HYDROBROMIDE(UNII: TKS641KOAY) (VORTIOXETINE - UNII:3O2K1S3WQV)	VORTIOXETINE	20mg \| 15mg \| 10mg \| 5mg

Inactive Ingredients

Ingredient Name	Avera McKennan Hospital	Takeda Pharmaceuticals America, Inc.	REMEDYREPACK INC.
CELLULOSE, MICROCRYSTALLINE(OP1R32D61U)
FERRIC OXIDE RED(1K09F3G675)
FERRIC OXIDE YELLOW(EX438O2MRT)
HYDROXYPROPYL CELLULOSE (120000 MW)(UKE75GEA7F)
HYDROXYPROPYL CELLULOSE (90000 WAMW)(UKE75GEA7F)
HYDROXYPROPYL CELLULOSE (TYPE H)(RFW2ET671P)
HYPROMELLOSE 2910 (6 MPA.S)(0WZ8WG20P6)
MAGNESIUM STEARATE(70097M6I30)
MANNITOL(3OWL53L36A)
MICROCRYSTALLINE CELLULOSE(OP1R32D61U)
POLYETHYLENE GLYCOL 400(B697894SGQ)
SODIUM STARCH GLYCOLATE TYPE A CORN(AG9B65PV6B)
SODIUM STARCH GLYCOLATE TYPE A POTATO(5856J3G2A2)
TITANIUM DIOXIDE(15FIX9V2JP)

Drug Product Composition: Vortioxetine Hydrobromide